Vertex to Announce First Quarter 2025 Financial Results on May 5th

Rhea-AI Summary

Vertex Pharmaceuticals (Nasdaq: VRTX) has scheduled its first quarter 2025 financial results announcement for Monday, May 5, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. ET to discuss the results.

Investors can access the call by dialing (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and referencing the 'Vertex Pharmaceuticals First Quarter 2025 Earnings Call.' A live webcast will be available through the Investors section of Vertex's website at www.vrtx.com. Participants are advised to register 15 minutes before the scheduled webcast to ensure timely connection. An archived version of the webcast will be available on the company's website.

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2025 financial results on Monday, May 5, 2025 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the “Vertex Pharmaceuticals First Quarter 2025 Earnings Call.”

The conference call will be webcast live and a link to the webcast can be accessed through Vertex's website at www.vrtx.com in the "Investors" section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1.

Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 15 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on LinkedIn, Facebook, Instagram, YouTube and X.

(VRTX-WEB)

View source version on businesswire.com: https://www.businesswire.com/news/home/20250407026196/en/

Vertex Pharmaceuticals Incorporated Investor Relations:

investorinfo@vrtx.com

Source: Vertex Pharmaceuticals Incorporated

FAQ

When will Vertex Pharmaceuticals (VRTX) release Q1 2025 earnings?

Vertex will release Q1 2025 earnings on Monday, May 5, 2025, after market close.

How can investors join Vertex's (VRTX) Q1 2025 earnings call?

Investors can dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) for the earnings call at 4:30 p.m. ET.

Where can I watch Vertex's (VRTX) Q1 2025 earnings webcast?

The webcast will be available in the Investors section of Vertex's website at www.vrtx.com.

What time is Vertex's (VRTX) Q1 2025 earnings call?

The earnings conference call and webcast will begin at 4:30 p.m. ET on May 5, 2025.